| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Stage |
TNM |
Type † |
|
A1 |
1 |
M |
68 |
Stomach |
Adenocarcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
A2 |
2 |
M |
66 |
Stomach |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
A3 |
3 |
F |
62 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
|
A4 |
4 |
M |
56 |
Stomach |
Adenocarcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
A5 |
5 |
M |
77 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
|
A6 |
6 |
F |
59 |
Skin |
Malignant melanoma of left upper limb |
– |
II |
T4N0M0 |
Malignant |
|
A7 |
7 |
M |
65 |
Skin |
Malignant melanoma of scalp |
– |
II |
T4N0M0 |
Malignant |
|
A8 |
8 |
M |
57 |
Skin |
Malignant melanoma of left shoulder |
– |
II |
T4N0M0 |
Malignant |
|
A9 |
9 |
M |
53 |
Skin |
Malignant melanoma of left footplate |
– |
II |
T4N0M0 |
Malignant |
|
A10 |
10 |
M |
66 |
Skin |
Malignant melanoma of right thigh |
– |
II |
T4N0M0 |
Malignant |
|
A11 |
11 |
M |
66 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:3+3) |
2 |
IV |
T3N1M1 |
Malignant |
|
A12 |
12 |
M |
60 |
Prostate |
Adenocarcinoma (prostate tissue) |
– |
IV |
T4N1M1c |
Malignant |
|
A13 |
13 |
M |
73 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:3+4) |
2 |
– |
– |
Malignant |
|
A14 |
14 |
M |
69 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:2+4) |
2 |
III |
T3N0M0 |
Malignant |
|
A15 |
15 |
M |
65 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:3+4) |
2 |
II |
T2N0M0 |
Malignant |
|
A16 |
16 |
F |
50 |
Brain |
Astrocytoma |
3–4 |
– |
– |
Malignant |
|
A17 |
17 |
M |
51 |
Brain |
Astrocytoma |
3–4 |
– |
– |
Malignant |
|
A18 |
18 |
M |
56 |
Brain |
Astrocytoma |
3–4 |
– |
– |
Malignant |
|
A19 |
19 |
F |
46 |
Brain |
Astrocytoma |
3–4 |
– |
– |
Malignant |
|
A20 |
20 |
M |
35 |
Brain |
Astrocytoma |
3–4 |
– |
– |
Malignant |
|
A21 |
21 |
F |
26 |
Ovary |
Serous cystadenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
|
A22 |
22 |
F |
38 |
Ovary |
Serous cystadenocarcinoma |
1 |
IV |
T3cN1M1 |
Malignant |
|
A23 |
23 |
F |
57 |
Ovary |
Serous cystadenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
|
A24 |
24 |
F |
51 |
Ovary |
Serous papillary cystadenocarcinoma |
2 |
IIIc |
T3cN1M0 |
Malignant |
|
A25 |
25 |
F |
34 |
Ovary |
Serous papillary cystadenocarcinoma |
1 |
Ia |
T1aN0M0 |
Malignant |
|
B1 |
26 |
M |
55 |
Stomach |
Mucinous adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
B2 |
27 |
M |
64 |
Stomach |
Adenocarcinoma |
3 |
II |
T2N1M0 |
Malignant |
|
B3 |
28 |
M |
53 |
Stomach |
Adenocarcinoma (fibrous tissue and blood vessel) |
– |
II |
T3N0M0 |
Malignant |
|
B4 |
29 |
M |
48 |
Stomach |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
B5 |
30 |
M |
69 |
Stomach |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
B6 |
31 |
F |
46 |
Skin |
Malignant melanoma of thigh |
– |
II |
T4N0M0 |
Malignant |
|
B7 |
32 |
F |
47 |
Skin |
Malignant melanoma of right upper arm |
– |
II |
T2N0M0 |
Malignant |
|
B8 |
33 |
M |
61 |
Skin |
Malignant melanoma of right footplate |
– |
II |
T4N0M0 |
Malignant |
|
B9 |
34 |
M |
52 |
Skin |
Malignant melanoma of right heel |
– |
IV |
T4N1M1 |
Malignant |
|
B10 |
35 |
M |
38 |
Skin |
Malignant melanoma of abdominal wall |
– |
III |
T4N1M0 |
Malignant |
|
B11 |
36 |
M |
73 |
Prostate |
Adenocarcinoma (Gleason grade:4 Gleason score:4+5) |
3 |
IV |
T3N1M1c |
Malignant |
|
B12 |
37 |
M |
75 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:2+4) |
2 |
IV |
T4N1M1c |
Malignant |
|
B13 |
38 |
M |
80 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:3+4) |
2 |
IV |
T4N1M1c |
Malignant |
|
B14 |
39 |
M |
60 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:3+4) |
2 |
IV |
T3N1M1b |
Malignant |
|
B15 |
40 |
M |
78 |
Prostate |
Adenocarcinoma (blood vessel and adipose tissue) |
– |
IV |
T4N1M1b |
Malignant |
|
B16 |
41 |
F |
61 |
Cerebrum |
Astro-glioblastoma |
3–4 |
– |
– |
Malignant |
|
B17 |
42 |
F |
31 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
B18 |
43 |
M |
40 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
B19 |
44 |
M |
55 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
B20 |
45 |
F |
41 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
B21 |
46 |
F |
34 |
Ovary |
Serous papillary adenocarcinoma |
1 |
Ib |
T1bN0M0 |
Malignant |
|
B22 |
47 |
F |
50 |
Ovary |
Serous papillary adenocarcinoma |
3 |
I |
T1N0M0 |
Malignant |
|
B23 |
48 |
F |
46 |
Ovary |
Serous papillary adenocarcinoma with necrosis |
3 |
IIIc |
T2cN1M0 |
Malignant |
|
B24 |
49 |
F |
55 |
Ovary |
Serous papillary adenocarcinoma |
3 |
II |
T2N0M0 |
Malignant |
|
B25 |
50 |
F |
57 |
Ovary |
Serous papillary adenocarcinoma |
3 |
IIIc |
T3cN1M0 |
Malignant |
|
C1 |
51 |
M |
47 |
Stomach |
Adenocarcinoma |
3 |
II |
T2N1M0 |
Malignant |
|
C2 |
52 |
M |
60 |
Stomach |
Adenocarcinoma |
3 |
IIIa |
T4N0M0 |
Malignant |
|
C3 |
53 |
M |
55 |
Stomach |
Adenocarcinoma |
1 |
IIIb |
T4N2M0 |
Malignant |
|
C4 |
54 |
M |
46 |
Stomach |
Adenocarcinoma |
1 |
IIIb |
T3N2M0 |
Malignant |
|
C5 |
55 |
M |
53 |
Stomach |
Adenocarcinoma |
3 |
II |
T3N0M0 |
Malignant |
|
C6 |
56 |
F |
62 |
Skin |
Malignant melanoma of right thumb |
– |
II |
T4N0M0 |
Malignant |
|
C7 |
57 |
M |
45 |
Skin |
Malignant melanoma of crissum |
– |
II |
T4N0M0 |
Malignant |
|
C8 |
58 |
F |
66 |
Skin |
Malignant melanoma of chest wall |
– |
II |
T4N0M0 |
Malignant |
|
C9 |
59 |
M |
74 |
Skin |
Malignant melanoma of left footplate |
– |
II |
T4N0M0 |
Malignant |
|
C10 |
60 |
M |
55 |
Skin |
Malignant melanoma of right forearm |
– |
II |
T4N0M0 |
Malignant |
|
C11 |
61 |
M |
73 |
Prostate |
Adenocarcinoma (Gleason grade:5 Gleason score:5+4) |
3 |
IV |
T3N1M1b |
Malignant |
|
C12 |
62 |
M |
75 |
Prostate |
Adenocarcinoma (Gleason grade:5 Gleason score:5+5) |
3 |
IV |
T2N1M1c |
Malignant |
|
C13 |
63 |
M |
65 |
Prostate |
Adenocarcinoma (Gleason grade:5 Gleason score:4+5) |
3 |
IV |
T2N1M1 |
Malignant |
|
C14 |
64 |
M |
69 |
Prostate |
Adenocarcinoma (Gleason grade:5 Gleason score:5+5) |
3 |
II |
T2N0M0 |
Malignant |
|
C15 |
65 |
M |
38 |
Prostate |
Adenocarcinoma (hyperplasia) |
– |
III |
T4N0M0 |
Malignant |
|
C16 |
66 |
F |
55 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
C17 |
67 |
F |
32 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
C18 |
68 |
M |
39 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
C19 |
69 |
F |
59 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
C20 |
70 |
M |
44 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
C21 |
71 |
F |
42 |
Ovary |
Serous papillary adenocarcinoma |
3 |
II |
T2N0M0 |
Malignant |
|
C22 |
72 |
F |
48 |
Ovary |
Serous papillary adenocarcinoma |
3 |
Ia |
T1aN0M0 |
Malignant |
|
C23 |
73 |
F |
46 |
Ovary |
Mucinous adenocarcinoma |
1 |
Ia |
T1aN0M0 |
Malignant |
|
C24 |
74 |
F |
34 |
Ovary |
Mucinous adenocarcinoma |
1 |
I |
T1N0M0 |
Malignant |
|
C25 |
75 |
F |
48 |
Ovary |
Mucinous adenocarcinoma |
1 |
Ib |
T1bN0M0 |
Malignant |
|
D1 |
76 |
M |
58 |
Stomach |
Adenocarcinoma |
3 |
II |
T3N0M0 |
Malignant |
|
D2 |
77 |
M |
30 |
Stomach |
Adenocarcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
D3 |
78 |
M |
67 |
Stomach |
Adenocarcinoma (smooth muscle and blood vessel) |
– |
II |
T3N0M0 |
Malignant |
|
D4 |
79 |
M |
43 |
Stomach |
Adenocarcinoma (sparse) |
– |
IIIa |
T3N1M0 |
Malignant |
|
D5 |
80 |
F |
55 |
Stomach |
Adenocarcinoma |
3 |
IIIb |
T3N3M0 |
Malignant |
|
D6 |
81 |
F |
38 |
Intestinal mucous membrane |
Malignant melanoma of rectum |
– |
– |
– |
Malignant |
|
D7 |
82 |
F |
72 |
Intestinal mucous membrane |
Malignant melanoma of rectum |
– |
– |
– |
Malignant |
|
D8 |
83 |
F |
69 |
Intestinal mucous membrane |
Malignant melanoma of rectum |
– |
– |
– |
Malignant |
|
D9 |
84 |
M |
66 |
Intestinal mucous membrane |
Malignant melanoma of rectum |
– |
– |
– |
Malignant |
|
D10 |
85 |
M |
73 |
Intestinal mucous membrane |
Malignant melanoma of small intestine |
– |
– |
– |
Malignant |
|
D11 |
86 |
M |
66 |
Prostate |
Adenocarcinoma with necrosis (Gleason grade:5 Gleason score:5+5) |
3 |
II |
T2N0M0 |
Malignant |
|
D12 |
87 |
M |
76 |
Prostate |
Adenocarcinoma (Gleason grade:5 Gleason score:5+5) |
3 |
IV |
T3N1M1b |
Malignant |
|
D13 |
88 |
M |
82 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:3+4) |
2–3 |
II |
T2N0M0 |
Malignant |
|
D14 |
89 |
M |
63 |
Prostate |
Adenocarcinoma (Gleason grade:3 Gleason score:2+4) |
2 |
IV |
T2N1M1b |
Malignant |
|
D15 |
90 |
M |
73 |
Prostate |
Adenocarcinoma (Gleason grade:4 Gleason score:5+3) |
2–3 |
IV |
T4N1M1c |
Malignant |
|
D16 |
91 |
F |
41 |
Cerebrum |
Astrocytoma |
2 |
– |
– |
Malignant |
|
D17 |
92 |
F |
50 |
Cerebrum |
Astrocytoma |
3 |
– |
– |
Malignant |
|
D18 |
93 |
M |
53 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
D19 |
94 |
F |
49 |
Cerebrum |
Astrocytoma |
3–4 |
– |
– |
Malignant |
|
D20 |
95 |
M |
48 |
Cerebrum |
Glioblastoma |
4 |
– |
– |
Malignant |
|
D21 |
96 |
F |
65 |
Ovary |
Serous papillary adenocarcinoma |
– |
IIa |
T2aN0M0 |
Malignant |
|
D22 |
97 |
F |
49 |
Ovary |
Mucinous adenocarcinoma |
2 |
Ia |
T1aN0M0 |
Malignant |
|
D23 |
98 |
F |
67 |
Ovary |
Mucinous adenocarcinoma (fibrous tissue and mucous tissue) |
– |
IIIb |
T3bN0M0 |
Malignant |
|
D24 |
99 |
F |
41 |
Ovary |
Mucinous adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
|
D25 |
100 |
F |
29 |
Ovary |
Mucinous adenocarcinoma |
3 |
III |
T3N0M0 |
Malignant |
|
E1 |
101 |
M |
25 |
Stomach |
Normal stomach tissue |
– |
– |
– |
Normal |
|
E2 |
102 |
M |
50 |
Stomach |
Normal stomach tissue |
– |
– |
– |
Normal |
|
E3 |
103 |
M |
16 |
Stomach |
Normal stomach tissue (fibrous tissue and blood vessel) |
– |
– |
– |
Normal |
|
E4 |
104 |
F |
15 |
Stomach |
Normal stomach tissue (stomach mucous membrane) |
– |
– |
– |
Normal |
|
E5 |
105 |
M |
35 |
Stomach |
Normal stomach tissue |
– |
– |
– |
Normal |
|
E6 |
106 |
M |
45 |
Skin |
Normal skin tissue (skin appendages) |
– |
– |
– |
Normal |
|
E7 |
107 |
M |
30 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
E8 |
108 |
F |
18 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
E9 |
109 |
M |
25 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
E10 |
110 |
M |
47 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
E11 |
111 |
M |
31 |
Prostate |
Normal prostate tissue |
– |
– |
– |
Normal |
|
E12 |
112 |
M |
32 |
Prostate |
Normal prostate tissue (smooth muscle) |
– |
– |
– |
Normal |
|
E13 |
113 |
M |
35 |
Prostate |
Normal prostate tissue |
– |
– |
– |
Normal |
|
E14 |
114 |
M |
38 |
Prostate |
Normal prostate tissue |
– |
– |
– |
Normal |
|
E15 |
115 |
M |
35 |
Prostate |
Normal prostate tissue |
– |
– |
– |
Normal |
|
E16 |
116 |
F |
28 |
Brain |
Normal brain tissue |
– |
– |
– |
Normal |
|
E17 |
117 |
M |
26 |
Brain |
Normal brain tissue |
– |
– |
– |
Normal |
|
E18 |
118 |
F |
42 |
Brain |
Normal brain tissue |
– |
– |
– |
Normal |
|
E19 |
119 |
F |
38 |
Brain |
Normal brain tissue |
– |
– |
– |
Normal |
|
E20 |
120 |
F |
50 |
Brain |
Normal brain tissue |
– |
– |
– |
Normal |
|
E21 |
121 |
F |
18 |
Ovary |
Normal ovary tissue |
– |
– |
– |
Normal |
|
E22 |
122 |
F |
19 |
Ovary |
Normal ovary tissue |
– |
– |
– |
Normal |
|
E23 |
123 |
F |
27 |
Ovary |
Normal ovary tissue |
– |
– |
– |
Normal |
|
E24 |
124 |
F |
34 |
Ovary |
Normal ovary tissue |
– |
– |
– |
Normal |
|
E25 |
125 |
F |
41 |
Ovary |
Normal ovary tissue |
– |
– |
– |
Normal |
|
F1 |
126 |
F |
55 |
Breast |
Invasive ductal carcinoma |
– |
IIa |
T2N0M0 |
Malignant |
|
F2 |
127 |
F |
59 |
Breast |
Invasive ductal carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
F3 |
128 |
F |
53 |
Breast |
Invasive ductal carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
F4 |
129 |
F |
43 |
Breast |
Invasive ductal carcinoma (breast tissue) |
– |
IIb |
T3N0M0 |
Malignant |
|
F5 |
130 |
F |
48 |
Breast |
Invasive ductal carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
F6 |
131 |
M |
30 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
F7 |
132 |
M |
52 |
Testis |
Seminoma |
– |
I |
T2N0M0 |
Malignant |
|
F8 |
133 |
M |
36 |
Testis |
Seminoma |
– |
I |
T2N0M0 |
Malignant |
|
F9 |
134 |
M |
70 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
F10 |
135 |
M |
31 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
F11 |
136 |
M |
58 |
Colon |
Adenocarcinoma |
1 |
III |
T4N1M0 |
Malignant |
|
F12 |
137 |
M |
27 |
Colon |
Adenocarcinoma |
2 |
II |
T4N0M0 |
Malignant |
|
F13 |
138 |
M |
61 |
Colon |
Adenocarcinoma |
2 |
II |
T4N0M0 |
Malignant |
|
F14 |
139 |
M |
65 |
Colon |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
F15 |
140 |
M |
44 |
Colon |
Adenocarcinoma |
2 |
II |
T4N0M0 |
Malignant |
|
F16 |
141 |
M |
71 |
Bladder |
Urothelial carcinoma |
1 |
II |
T2bN0M0 |
Malignant |
|
F17 |
142 |
M |
45 |
Bladder |
Urothelial carcinoma (fibrous tissue and blood vessel) |
– |
I |
T1N0M0 |
Malignant |
|
F18 |
143 |
M |
57 |
Bladder |
Urothelial carcinoma |
1 |
I |
T1N0M0 |
Malignant |
|
F19 |
144 |
M |
66 |
Bladder |
Urothelial carcinoma |
1 |
I |
T1N0M0 |
Malignant |
|
F20 |
145 |
M |
42 |
Bladder |
Urothelial carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
F21 |
146 |
F |
66 |
Uterus |
Endometrioid adenocarcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
F22 |
147 |
F |
59 |
Uterus |
Endometrioid adenocarcinoma |
1 |
Ib |
T1bN0M0 |
Malignant |
|
F23 |
148 |
F |
55 |
Uterus |
Endometrioid adenocarcinoma |
1 |
IIa |
T2aN0M0 |
Malignant |
|
F24 |
149 |
F |
48 |
Uterus |
Endometrioid adenocarcinoma |
1 |
Ib |
T1bN0M0 |
Malignant |
|
F25 |
150 |
F |
60 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
|
G1 |
151 |
F |
45 |
Breast |
Invasive ductal carcinoma |
1 |
IIa |
T2N0M0 |
Malignant |
|
G2 |
152 |
F |
52 |
Breast |
Invasive ductal carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
G3 |
153 |
F |
34 |
Breast |
Invasive ductal carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
G4 |
154 |
F |
68 |
Breast |
Invasive ductal carcinoma (fibrous tissue and blood vessel) |
– |
IIa |
T2N0M0 |
Malignant |
|
G5 |
155 |
F |
42 |
Breast |
Invasive ductal carcinoma |
1 |
IIb |
T3N0M0 |
Malignant |
|
G6 |
156 |
M |
45 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
G7 |
157 |
M |
55 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
G8 |
158 |
M |
30 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
G9 |
159 |
M |
52 |
Testis |
Seminoma with necrosis |
– |
I |
T2N0M0 |
Malignant |
|
G10 |
160 |
M |
55 |
Testis |
Seminoma |
– |
I |
T2N0M0 |
Malignant |
|
G11 |
161 |
F |
65 |
Colon |
Adenocarcinoma |
1 |
II |
T3N0M0 |
Malignant |
|
G12 |
162 |
M |
26 |
Colon |
Adenocarcinoma (sparse) |
3 |
IV |
T3N2M1 |
Malignant |
|
G13 |
163 |
M |
70 |
Colon |
Adenocarcinoma |
1 |
I |
T2N0M0 |
Malignant |
|
G14 |
164 |
M |
60 |
Colon |
Adenocarcinoma |
1 |
II |
T3N0M0 |
Malignant |
|
G15 |
165 |
M |
75 |
Colon |
Adenocarcinoma |
2 |
II |
T4N0M0 |
Malignant |
|
G16 |
166 |
F |
54 |
Bladder |
Urothelial carcinoma |
2 |
IV |
T3N0M1 |
Malignant |
|
G17 |
167 |
M |
67 |
Bladder |
Urothelial carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
G18 |
168 |
M |
63 |
Bladder |
Urothelial carcinoma (sparse) |
1 |
II |
T2N0M0 |
Malignant |
|
G19 |
169 |
F |
58 |
Bladder |
Urothelial carcinoma |
1 |
II |
T2bN0M0 |
Malignant |
|
G20 |
170 |
M |
66 |
Bladder |
Urothelial carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
G21 |
171 |
F |
51 |
Uterus |
Endometrioid adenocarcinoma |
1 |
Ib |
T1bN0M0 |
Malignant |
|
G22 |
172 |
F |
44 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
|
G23 |
173 |
F |
61 |
Uterus |
Endometrioid adenocarcinoma |
1 |
Ic |
T1cN0M0 |
Malignant |
|
G24 |
174 |
F |
42 |
Uterus |
Endometrioid adenocarcinoma |
– |
Ib |
T2bN0M0 |
Malignant |
|
G25 |
175 |
F |
50 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
|
H1 |
176 |
F |
47 |
Breast |
Invasive ductal carcinoma (tumoral necrosis) |
– |
IIa |
T2N0M0 |
Malignant |
|
H2 |
177 |
F |
48 |
Breast |
Invasive ductal carcinoma |
2 |
IIIb |
T4N2M0 |
Malignant |
|
H3 |
178 |
F |
63 |
Breast |
Invasive ductal carcinoma |
1 |
IIa |
T2N0M0 |
Malignant |
|
H4 |
179 |
F |
49 |
Breast |
Invasive ductal carcinoma |
1 |
IIa |
T2N0M0 |
Malignant |
|
H5 |
180 |
F |
52 |
Breast |
Invasive ductal carcinoma |
2 |
IIb |
T3N0M0 |
Malignant |
|
H6 |
181 |
M |
33 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
H7 |
182 |
M |
39 |
Testis |
Seminoma |
– |
I |
T2N0M0 |
Malignant |
|
H8 |
183 |
M |
35 |
Testis |
Seminoma |
– |
I |
T4N0M0 |
Malignant |
|
H9 |
184 |
M |
34 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
H10 |
185 |
M |
39 |
Testis |
Seminoma |
– |
I |
T1N0M0 |
Malignant |
|
H11 |
186 |
F |
52 |
Colon |
Adenocarcinoma (lymph tissue) |
– |
II |
T3N0M0 |
Malignant |
|
H12 |
187 |
M |
44 |
Colon |
Adenocarcinoma |
2 |
II |
T4N0M0 |
Malignant |
|
H13 |
188 |
M |
50 |
Colon |
Adenocarcinoma |
2 |
II |
T4N0M0 |
Malignant |
|
H14 |
189 |
F |
33 |
Colon |
Adenocarcinoma |
2 |
II |
T4N0M0 |
Malignant |
|
H15 |
190 |
M |
66 |
Colon |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
H16 |
191 |
M |
50 |
Bladder |
Urothelial carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
H17 |
192 |
M |
65 |
Bladder |
Urothelial carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
H18 |
193 |
M |
71 |
Bladder |
Urothelial carcinoma |
2 |
II |
T2aN0M0 |
Malignant |
|
H19 |
194 |
F |
64 |
Bladder |
Urothelial carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
H20 |
195 |
M |
76 |
Bladder |
Urothelial carcinoma |
2 |
II |
T3aN0M0 |
Malignant |
|
H21 |
196 |
F |
55 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
|
H22 |
197 |
F |
62 |
Uterus |
Endometrioid adenocarcinoma |
3 |
IIIc |
T1cN1M0 |
Malignant |
|
H23 |
198 |
F |
77 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
|
H24 |
199 |
F |
58 |
Uterus |
Endometrioid adenocarcinoma (smooth muscle) |
– |
Ib |
T1bN0M0 |
Malignant |
|
H25 |
200 |
F |
62 |
Uterus |
Endometrioid adenocarcinoma |
3 |
I |
T1N0M0 |
Malignant |
|
I1 |
201 |
F |
36 |
Breast |
Invasive ductal carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
I2 |
202 |
F |
51 |
Breast |
Invasive ductal carcinoma |
2 |
IIIa |
T2N2M0 |
Malignant |
|
I3 |
203 |
F |
64 |
Breast |
Invasive ductal carcinoma |
1 |
IIa |
T2N0M0 |
Malignant |
|
I4 |
204 |
F |
35 |
Breast |
Invasive ductal carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
I5 |
205 |
F |
55 |
Breast |
Invasive ductal carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
I6 |
206 |
M |
21 |
Testis |
Embryonal carcinoma (fibrous tissue and blood vessel) |
– |
I |
T2N0M0 |
Malignant |
|
I7 |
207 |
M |
30 |
Testis |
Embryonal carcinoma |
– |
I |
T2N0M0 |
Malignant |
|
I8 |
208 |
M |
23 |
Testis |
Embryonal carcinoma |
– |
I |
T1N0M0 |
Malignant |
|
I9 |
209 |
M |
36 |
Testis |
Embryonal carcinoma |
– |
I |
T1N0M0 |
Malignant |
|
I10 |
210 |
M |
28 |
Testis |
Embryonal carcinoma |
– |
I |
T1N0M0 |
Malignant |
|
I11 |
211 |
M |
53 |
Colon |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
I12 |
212 |
F |
76 |
Colon |
Adenocarcinoma |
2 |
I |
T2N0M0 |
Malignant |
|
I13 |
213 |
M |
39 |
Colon |
Adenocarcinoma |
2 |
II |
T4N0M0 |
Malignant |
|
I14 |
214 |
F |
72 |
Colon |
Adenocarcinoma |
3 |
III |
T4N1M0 |
Malignant |
|
I15 |
215 |
M |
37 |
Colon |
Adenocarcinoma |
3 |
IIIb |
T4N1M0 |
Malignant |
|
I16 |
216 |
F |
45 |
Bladder |
Urothelial carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
I17 |
217 |
F |
61 |
Bladder |
Urothelial carcinoma |
2 |
II |
T3aN0M0 |
Malignant |
|
I18 |
218 |
M |
71 |
Bladder |
Urothelial carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
I19 |
219 |
M |
66 |
Bladder |
Urothelial carcinoma (sparse) |
– |
III |
T3bN0M0 |
Malignant |
|
I20 |
220 |
F |
48 |
Bladder |
Urothelial carcinoma |
3 |
II |
T2bN0M0 |
Malignant |
|
I21 |
221 |
F |
60 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ia |
T1aN0M0 |
Malignant |
|
I22 |
222 |
F |
58 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
|
I23 |
223 |
F |
54 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
|
I24 |
224 |
F |
55 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
|
I25 |
225 |
F |
63 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ic |
T1cN0M0 |
Malignant |
|
J1 |
226 |
F |
35 |
Breast |
Normal breast tissue (fibrofatty tissue and blood vessel) |
– |
– |
– |
NAT |
|
J2 |
227 |
F |
43 |
Breast |
Normal breast tissue (fibrofatty tissue and blood vessel) |
– |
– |
– |
NAT |
|
J3 |
228 |
F |
46 |
Breast |
Normal breast tissue |
– |
– |
– |
NAT |
|
J4 |
229 |
F |
50 |
Breast |
Normal breast tissue |
– |
– |
– |
NAT |
|
J5 |
230 |
F |
35 |
Breast |
Normal breast tissue |
– |
– |
– |
Normal |
|
J6 |
231 |
M |
33 |
Testis |
Normal testis tissue |
– |
– |
– |
Normal |
|
J7 |
232 |
M |
45 |
Testis |
Normal testis tissue |
– |
– |
– |
Normal |
|
J8 |
233 |
M |
30 |
Testis |
Normal testis tissue |
– |
– |
– |
Normal |
|
J9 |
234 |
M |
50 |
Testis |
Normal testis tissue |
– |
– |
– |
Normal |
|
J10 |
235 |
M |
45 |
Testis |
Normal testis tissue |
– |
– |
– |
Normal |
|
J11 |
236 |
M |
30 |
Colon |
Normal colon tissue |
– |
– |
– |
Normal |
|
J12 |
237 |
M |
33 |
Colon |
Normal colon tissue |
– |
– |
– |
Normal |
|
J13 |
238 |
M |
28 |
Colon |
Normal colon tissue |
– |
– |
– |
Normal |
|
J14 |
239 |
M |
30 |
Colon |
Normal colon tissue |
– |
– |
– |
Normal |
|
J15 |
240 |
M |
38 |
Colon |
Normal colon tissue |
– |
– |
– |
Normal |
|
J16 |
241 |
M |
35 |
Bladder |
Normal bladder tissue (fibrous tissue and blood vessel) |
– |
– |
– |
Normal |
|
J17 |
242 |
M |
50 |
Bladder |
Normal bladder tissue |
– |
– |
– |
Normal |
|
J18 |
243 |
M |
22 |
Bladder |
Normal bladder tissue (sparse) |
– |
– |
– |
Normal |
|
J19 |
244 |
M |
48 |
Bladder |
Normal bladder tissue |
– |
– |
– |
Normal |
|
J20 |
245 |
M |
43 |
Bladder |
Normal bladder tissue (smooth muscle) |
– |
– |
– |
Normal |
|
J21 |
246 |
F |
40 |
Uterine |
Normal endometrium tissue (smooth muscle) |
– |
– |
– |
Normal |
|
J22 |
247 |
F |
18 |
Uterine |
Normal endometrium tissue (sparse) |
– |
– |
– |
Normal |
|
J23 |
248 |
F |
18 |
Uterine |
Normal endometrium tissue |
– |
– |
– |
Normal |
|
J24 |
249 |
F |
21 |
Uterine |
Normal endometrium tissue |
– |
– |
– |
Normal |
|
J25 |
250 |
F |
21 |
Uterine |
Normal endometrium tissue |
– |
– |
– |
Normal |
|
K1 |
251 |
F |
56 |
Thyroid |
Papillary carcinoma |
– |
II |
T2N0M0 |
Malignant |
|
K2 |
252 |
F |
33 |
Thyroid |
Papillary carcinoma |
– |
I |
T1N0M0 |
Malignant |
|
K3 |
253 |
M |
25 |
Thyroid |
Papillary carcinoma |
– |
I |
T1N0M0 |
Malignant |
|
K4 |
254 |
F |
56 |
Thyroid |
Papillary carcinoma |
– |
II |
T2N0M0 |
Malignant |
|
K5 |
255 |
F |
55 |
Thyroid |
Papillary carcinoma |
– |
II |
T2N0M0 |
Malignant |
|
K6 |
256 |
M |
50 |
Lung |
Squamous cell carcinoma |
2 |
IIIb |
T4N1M0 |
Malignant |
|
K7 |
257 |
M |
52 |
Lung |
Squamous cell carcinoma |
3 |
II |
T2N1M0 |
Malignant |
|
K8 |
258 |
M |
58 |
Lung |
Squamous cell carcinoma |
2 |
II |
T2N1M0 |
Malignant |
|
K9 |
259 |
M |
77 |
Lung |
Squamous cell carcinoma |
2 |
IIIa |
T3N2M0 |
Malignant |
|
K10 |
260 |
M |
59 |
Lung |
Squamous cell carcinoma |
3 |
II |
T2N1M0 |
Malignant |
|
K11 |
261 |
M |
68 |
Head and neck |
Squamous cell carcinoma of right hupeh |
1 |
II |
T2N0M0 |
Malignant |
|
K12 |
262 |
F |
51 |
Head and neck |
Squamous cell carcinoma of buccal region |
1 |
IV |
T4N0M0 |
Malignant |
|
K13 |
263 |
M |
40 |
Head and neck |
Squamous cell carcinoma of upper jaw |
1 |
IV |
T4N0M0 |
Malignant |
|
K14 |
264 |
F |
54 |
Head and neck |
Squamous cell carcinoma of lower lip |
1 |
IV |
T1N0M1 |
Malignant |
|
K15 |
265 |
M |
70 |
Head and neck |
Squamous cell carcinoma of buccal region (skeletal muscle and blood vessel) |
– |
II |
T2N0M0 |
Malignant |
|
K16 |
266 |
F |
37 |
Lymph node |
Hodgkin's disease of left neck |
– |
– |
– |
Malignant |
|
K17 |
267 |
M |
50 |
Lymph node |
Hodgkin's disease of right armpit |
– |
– |
– |
Malignant |
|
K18 |
268 |
M |
24 |
Lymph node |
Hodgkin's disease of neck |
– |
– |
– |
Malignant |
|
K19 |
269 |
M |
32 |
Lymph node |
Hodgkin's disease of neck |
– |
– |
– |
Malignant |
|
K20 |
270 |
M |
41 |
Lymph node |
Hodgkin's disease of neck |
– |
– |
– |
Malignant |
|
K21 |
271 |
M |
52 |
Soft tissue |
Fibrosarcoma of left thigh |
– |
IIIa G3 |
T1bN0M0 |
Malignant |
|
K22 |
272 |
M |
36 |
Soft tissue |
Fibrosarcoma of chest wall |
– |
IIb G2 |
T2aN0M0 |
Malignant |
|
K23 |
273 |
F |
25 |
Soft tissue |
Fibrosarcoma of left waist |
– |
IIb G2 |
T2bN0M0 |
Malignant |
|
K24 |
274 |
F |
38 |
Soft tissue |
Fibrosarcoma of left chest wall |
– |
Ib G1 |
T1bN0M0 |
Malignant |
|
K25 |
275 |
F |
60 |
Soft tissue |
Fibrosarcoma of abdominal wall |
– |
Ib G1 |
T2bN0M0 |
Malignant |
|
L1 |
276 |
M |
67 |
Thyroid |
Papillary carcinoma |
– |
II |
T2N0M0 |
Malignant |
|
L2 |
277 |
F |
28 |
Thyroid |
Papillary carcinoma |
– |
I |
T2N0M0 |
Malignant |
|
L3 |
278 |
F |
26 |
Thyroid |
Papillary carcinoma |
– |
I |
T2N0M0 |
Malignant |
|
L4 |
279 |
F |
30 |
Thyroid |
Papillary carcinoma |
– |
I |
T2N0M0 |
Malignant |
|
L5 |
280 |
F |
40 |
Thyroid |
Papillary carcinoma |
– |
I |
T2N0M0 |
Malignant |
|
L6 |
281 |
F |
35 |
Lung |
Squamous cell carcinoma |
3 |
IIIb |
T4N1M0 |
Malignant |
|
L7 |
282 |
M |
56 |
Lung |
Squamous cell carcinoma |
3 |
I |
T2N0M0 |
Malignant |
|
L8 |
283 |
M |
49 |
Lung |
Squamous cell carcinoma |
3 |
I |
T1N0M0 |
Malignant |
|
L9 |
284 |
M |
45 |
Lung |
Squamous cell carcinoma |
3 |
IIIb |
T4N0M0 |
Malignant |
|
L10 |
285 |
M |
64 |
Lung |
Squamous cell carcinoma |
3 |
IIIa |
T3N1M0 |
Malignant |
|
L11 |
286 |
M |
63 |
Head and neck |
Squamous cell carcinoma of nasopharynx |
1 |
I |
T1N0M0 |
Malignant |
|
L12 |
287 |
M |
81 |
Head and neck |
Squamous cell carcinoma of oral lip |
2 |
II |
T2N0M0 |
Malignant |
|
L13 |
288 |
F |
86 |
Head and neck |
Squamous cell carcinoma of lower lip |
1 |
IV |
T4N0M0 |
Malignant |
|
L14 |
289 |
M |
55 |
Head and neck |
Squamous cell carcinoma of buccal region |
1 |
I |
T1N0M0 |
Malignant |
|
L15 |
290 |
F |
63 |
Head and neck |
Squamous cell carcinoma of soft hupeh |
2 |
III |
T3N0M0 |
Malignant |
|
L16 |
291 |
M |
27 |
Lymph node |
Hodgkin's disease of left groin |
– |
– |
– |
Malignant |
|
L17 |
292 |
M |
17 |
Lymph node |
Hodgkin's disease of right neck |
– |
– |
– |
Malignant |
|
L18 |
293 |
M |
34 |
Lymph node |
Hodgkin's disease of right neck |
– |
– |
– |
Malignant |
|
L19 |
294 |
M |
3 |
Lymph node |
Hodgkin's disease of right neck |
– |
– |
– |
Malignant |
|
L20 |
295 |
M |
27 |
Lymph node |
Hodgkin's disease of neck |
– |
– |
– |
Malignant |
|
L21 |
296 |
M |
18 |
Soft tissue |
Fibrosarcoma of right upper arm |
– |
Ib G1 |
T1bN0M0 |
Malignant |
|
L22 |
297 |
F |
24 |
Soft tissue |
Fibrosarcoma of right oxter |
– |
Ia G1 |
T1aN0M0 |
Malignant |
|
L23 |
298 |
M |
32 |
Soft tissue |
Fibrosarcoma of left groin |
– |
Ia G1 |
T1bN0M0 |
Malignant |
|
L24 |
299 |
F |
39 |
Soft tissue |
Fibrosarcoma of left leg |
– |
Ia G1 |
T1N0M0 |
Malignant |
|
L25 |
300 |
F |
27 |
Soft tissue |
Fibrosarcoma of right abdominal part |
– |
IIb G2 |
T2aN0M0 |
Malignant |
|
M1 |
301 |
F |
36 |
Thyroid |
Follicular carcinoma |
– |
I |
T3N0M0 |
Malignant |
|
M2 |
302 |
F |
26 |
Thyroid |
Follicular carcinoma |
– |
I |
T2N0M0 |
Malignant |
|
M3 |
303 |
F |
48 |
Thyroid |
Follicular carcinoma |
– |
I |
T1N0M0 |
Malignant |
|
M4 |
304 |
F |
46 |
Thyroid |
Follicular carcinoma |
– |
I |
T1N0M0 |
Malignant |
|
M5 |
305 |
F |
60 |
Thyroid |
Follicular carcinoma |
– |
I |
T1N0M0 |
Malignant |
|
M6 |
306 |
F |
55 |
Lung |
Adenocarcinoma (chronic inflammation of tunica mucosa bronchiorum) |
– |
II |
T2N1M0 |
Malignant |
|
M7 |
307 |
F |
52 |
Lung |
Adenocarcinoma (sparse) |
– |
II |
T2N1M0 |
Malignant |
|
M8 |
308 |
M |
31 |
Lung |
Adenocarcinoma |
3 |
II |
T2N1M0 |
Malignant |
|
M9 |
309 |
M |
67 |
Lung |
Adenocarcinoma (fibrous tissue) |
– |
I |
T2N0M0 |
Malignant |
|
M10 |
310 |
M |
74 |
Lung |
Adenocarcinoma |
2 |
I |
T2N0M0 |
Malignant |
|
M11 |
311 |
M |
70 |
Head and neck |
Squamous cell carcinoma of left maxillary sinus |
2 |
II |
T2N0M0 |
Malignant |
|
M12 |
312 |
M |
47 |
Head and neck |
Squamous cell carcinoma of accessory nasal cavity |
2 |
II |
T2N0M0 |
Malignant |
|
M13 |
313 |
M |
78 |
Head and neck |
Squamous cell carcinoma of oral lip |
2 |
I |
T1N0M0 |
Malignant |
|
M14 |
314 |
M |
43 |
Head and neck |
Squamous cell carcinoma (tumoral necrosis of left nasal cavity) |
– |
II |
T3N0M0 |
Malignant |
|
M15 |
315 |
M |
34 |
Head and neck |
Squamous cell carcinoma of left ethmoid sinus |
3 |
II |
T2N0M0 |
Malignant |
|
M16 |
316 |
F |
48 |
Lymph node |
Diffuse B cell lymphoma of right groin |
– |
– |
– |
Malignant |
|
M17 |
317 |
F |
38 |
Lymph node |
Diffuse B cell lymphoma of right orbital |
– |
– |
– |
Malignant |
|
M18 |
318 |
M |
74 |
Lymph node |
Diffuse B cell lymphoma of left fossa poplitea |
– |
– |
– |
Malignant |
|
M19 |
319 |
M |
51 |
Lymph node |
Diffuse B cell lymphoma of left neck |
– |
– |
– |
Malignant |
|
M20 |
320 |
F |
29 |
Lymph node |
Diffuse B cell lymphoma of left oxter |
– |
– |
– |
Malignant |
|
M21 |
321 |
F |
42 |
Soft tissue |
Well differentiated liposarcoma of left thigh |
– |
Ia G1 |
T1aN0M0 |
Malignant |
|
M22 |
322 |
M |
58 |
Soft tissue |
Well differentiated liposarcoma of right thigh |
– |
Ib G1 |
T2aN0M0 |
Malignant |
|
M23 |
323 |
M |
39 |
Soft tissue |
Well differentiated liposarcoma of back |
– |
Ib G1 |
T2aN0M0 |
Malignant |
|
M24 |
324 |
M |
72 |
Soft tissue |
Well differentiated liposarcoma of right thigh |
– |
Ia G1 |
T1N0M0 |
Malignant |
|
M25 |
325 |
M |
62 |
Soft tissue |
Well differentiated liposarcoma of back |
– |
Ib G1 |
T2aN0M0 |
Malignant |
|
N1 |
326 |
F |
75 |
Thyroid |
Follicular carcinoma |
– |
III |
T4N0M0 |
Malignant |
|
N2 |
327 |
F |
48 |
Thyroid |
Follicular carcinoma |
– |
II |
T2N0M0 |
Malignant |
|
N3 |
328 |
F |
41 |
Thyroid |
Follicular carcinoma |
– |
I |
T2N0M0 |
Malignant |
|
N4 |
329 |
F |
63 |
Thyroid |
Follicular carcinoma |
– |
III |
T4N0M0 |
Malignant |
|
N5 |
330 |
M |
62 |
Thyroid |
Follicular carcinoma |
– |
II |
T2N0M0 |
Malignant |
|
N6 |
331 |
F |
39 |
Lung |
Adenocarcinoma |
3 |
II |
T2N1M0 |
Malignant |
|
N7 |
332 |
M |
70 |
Lung |
Adenocarcinoma (lung tissue) |
– |
I |
T1N0M0 |
Malignant |
|
N8 |
333 |
M |
68 |
Lung |
Adenocarcinoma |
3 |
I |
T2N0M0 |
Malignant |
|
N9 |
334 |
M |
55 |
Lung |
Adenocarcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
N10 |
335 |
F |
46 |
Lung |
Adenocarcinoma |
3 |
I |
T2N0M0 |
Malignant |
|
N11 |
336 |
M |
78 |
Oral cavity |
Squamous cell carcinoma of tongue |
1 |
II |
T2N0M0 |
Malignant |
|
N12 |
337 |
F |
39 |
Oral cavity |
Squamous cell carcinoma of tongue |
2 |
I |
T1N0M0 |
Malignant |
|
N13 |
338 |
F |
48 |
Oral cavity |
Squamous cell carcinoma of tongue |
1 |
II |
T2N0M0 |
Malignant |
|
N14 |
339 |
F |
41 |
Oral cavity |
Squamous cell carcinoma of tongue |
1 |
II |
T2N0M0 |
Malignant |
|
N15 |
340 |
M |
60 |
Oral cavity |
Squamous cell carcinoma of tongue |
3 |
– |
– |
Malignant |
|
N16 |
341 |
F |
45 |
Lymph node |
Diffuse B cell lymphoma of left oxter |
– |
– |
– |
Malignant |
|
N17 |
342 |
M |
10 |
Lymph node |
Diffuse small B cell lymphoma of left neck |
– |
– |
– |
Malignant |
|
N18 |
343 |
F |
50 |
Lymph node |
Diffuse B cell lymphoma of right oxter |
– |
– |
– |
Malignant |
|
N19 |
344 |
F |
57 |
Lymph node |
Diffuse B cell lymphoma of right neck |
– |
– |
– |
Malignant |
|
N20 |
345 |
F |
40 |
Lymph node |
Anaplastic large cell lymphoma of right groin |
– |
– |
– |
Malignant |
|
N21 |
346 |
F |
57 |
Soft tissue |
Mucinous liposarcoma of right thigh |
– |
IIa G2 |
T1N0M0 |
Malignant |
|
N22 |
347 |
M |
63 |
Soft tissue |
Mucinous liposarcoma of left oxter |
– |
IIb G2 |
T2bN0M0 |
Malignant |
|
N23 |
348 |
F |
34 |
Soft tissue |
Mucinous liposarcoma of retroperitoneum |
– |
IIb G2 |
T2bN0M0 |
Malignant |
|
N24 |
349 |
M |
60 |
Soft tissue |
Mucinous liposarcoma of right waist |
– |
IIb G2 |
T2bN0M0 |
Malignant |
|
N25 |
350 |
F |
36 |
Soft tissue |
Spindle cell type liposarcoma of retroperitoneum |
– |
IIb G2 |
T2aN0M0 |
Malignant |
|
O1 |
351 |
F |
18 |
Thyroid |
Normal thyroid tissue |
– |
– |
– |
Normal |
|
O2 |
352 |
F |
15 |
Thyroid |
Normal thyroid tissue |
– |
– |
– |
Normal |
|
O3 |
353 |
M |
50 |
Thyroid |
Normal thyroid tissue |
– |
– |
– |
Normal |
|
O4 |
354 |
M |
30 |
Thyroid |
Normal thyroid tissue |
– |
– |
– |
Normal |
|
O5 |
355 |
M |
50 |
Thyroid |
Normal thyroid tissue |
– |
– |
– |
Normal |
|
O6 |
356 |
M |
47 |
Lung |
Normal lung tissue |
– |
– |
– |
Normal |
|
O7 |
357 |
M |
50 |
Lung |
Normal lung tissue |
– |
– |
– |
Normal |
|
O8 |
358 |
F |
15 |
Lung |
Normal lung tissue |
– |
– |
– |
Normal |
|
O9 |
359 |
M |
47 |
Lung |
Normal lung tissue |
– |
– |
– |
Normal |
|
O10 |
360 |
M |
24 |
Lung |
Normal lung tissue |
– |
– |
– |
Normal |
|
O11 |
361 |
F |
19 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
O12 |
362 |
M |
35 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
O13 |
363 |
M |
33 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
O14 |
364 |
M |
28 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
O15 |
365 |
F |
40 |
Skin |
Normal skin tissue |
– |
– |
– |
Normal |
|
O16 |
366 |
M |
25 |
Lymph node |
Normal lymph node tissue |
– |
– |
– |
Normal |
|
O17 |
367 |
M |
30 |
Lymph node |
Normal lymph node tissue |
– |
– |
– |
Normal |
|
O18 |
368 |
M |
43 |
Lymph node |
Normal lymph node tissue |
– |
– |
– |
Normal |
|
O19 |
369 |
F |
21 |
Lymph node |
Normal lymph node tissue |
– |
– |
– |
Normal |
|
O20 |
370 |
F |
41 |
Lymph node |
Normal lymph node tissue |
– |
– |
– |
Normal |
|
O21 |
371 |
M |
40 |
Soft tissue |
Normal skeletal muscle tissue |
– |
– |
– |
Normal |
|
O22 |
372 |
M |
35 |
Soft tissue |
Normal skeletal muscle tissue |
– |
– |
– |
Normal |
|
O23 |
373 |
M |
22 |
Soft tissue |
Normal skeletal muscle tissue |
– |
– |
– |
Normal |
|
O24 |
374 |
M |
40 |
Soft tissue |
Normal skeletal muscle tissue |
– |
– |
– |
Normal |
|
O25 |
375 |
M |
50 |
Soft tissue |
Normal skeletal muscle tissue |
– |
– |
– |
Normal |
|
P1 |
376 |
M |
60 |
Liver |
Hepatocellular liver cancer |
2 |
II |
T2N0M0 |
Malignant |
|
P2 |
377 |
M |
58 |
Liver |
Hepatocellular liver cancer |
2 |
II |
T2N0M0 |
Malignant |
|
P3 |
378 |
M |
38 |
Liver |
Hepatocellular liver cancer |
2 |
III |
T3N0M0 |
Malignant |
|
P4 |
379 |
M |
49 |
Liver |
Hepatocellular liver cancer |
2 |
III |
T3N0M0 |
Malignant |
|
P5 |
380 |
M |
48 |
Liver |
Hepatocellular liver cancer |
2 |
II |
T2N0M0 |
Malignant |
|
P6 |
381 |
F |
47 |
Pancreas |
Adenocarcinoma (fibrous tissue and blood vessel) |
– |
II |
T3N0M0 |
Malignant |
|
P7 |
382 |
M |
57 |
Pancreas |
Adenocarcinoma |
1 |
I |
T2N0M0 |
Malignant |
|
P8 |
383 |
M |
52 |
Pancreas |
Adenocarcinoma (fibrous tissue and blood vessel) |
– |
II |
T3N0M0 |
Malignant |
|
P9 |
384 |
M |
77 |
Pancreas |
Adenocarcinoma |
1 |
I |
T2N0M0 |
Malignant |
|
P10 |
385 |
F |
46 |
Pancreas |
Adenocarcinoma |
1 |
II |
T3N0M0 |
Malignant |
|
P11 |
386 |
M |
65 |
Kidney |
Clear cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
P12 |
387 |
F |
45 |
Kidney |
Clear cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
P13 |
388 |
F |
57 |
Kidney |
Clear cell carcinoma |
1 |
I |
T1N0M0 |
Malignant |
|
P14 |
389 |
F |
47 |
Kidney |
Clear cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
P15 |
390 |
M |
51 |
Kidney |
Clear cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
P16 |
391 |
F |
42 |
Cervix uteri |
Squamous cell carcinoma |
1 |
Ib |
T1bN0M0 |
Malignant |
|
P17 |
392 |
F |
56 |
Cervix uteri |
Squamous cell carcinoma |
1 |
IIIb |
T1N1M0 |
Malignant |
|
P18 |
393 |
F |
50 |
Cervix uteri |
Squamous cell carcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
|
P19 |
394 |
F |
39 |
Cervix uteri |
Squamous cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
P20 |
395 |
F |
41 |
Cervix uteri |
Squamous cell carcinoma |
2 |
IIb |
T2bN0M0 |
Malignant |
|
P21 |
396 |
F |
72 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
P22 |
397 |
M |
62 |
Esophagus |
Squamous cell carcinoma |
1 |
III |
T3N1M0 |
Malignant |
|
P23 |
398 |
M |
64 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
P24 |
399 |
M |
48 |
Esophagus |
Squamous cell carcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
P25 |
400 |
M |
66 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
Q1 |
401 |
F |
32 |
Liver |
Hepatocellular liver cancer |
2 |
III |
T3N0M0 |
Malignant |
|
Q2 |
402 |
F |
55 |
Liver |
Hepatocellular liver cancer |
2 |
III |
T3N0M0 |
Malignant |
|
Q3 |
403 |
M |
36 |
Liver |
Hepatocellular liver cancer |
2 |
II |
T2N0M0 |
Malignant |
|
Q4 |
404 |
M |
71 |
Liver |
Hepatocellular liver cancer |
2 |
III |
T3N0M0 |
Malignant |
|
Q5 |
405 |
M |
52 |
Liver |
Hepatocellular liver cancer |
2 |
III |
T3N0M0 |
Malignant |
|
Q6 |
406 |
M |
45 |
Pancreas |
Adenocarcinoma |
2 |
I |
T2N0M0 |
Malignant |
|
Q7 |
407 |
F |
48 |
Pancreas |
Adenocarcinoma |
1 |
II |
T3N0M0 |
Malignant |
|
Q8 |
408 |
M |
52 |
Pancreas |
Adenocarcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
Q9 |
409 |
M |
39 |
Pancreas |
Adenocarcinoma |
1 |
II |
T3N0M0 |
Malignant |
|
Q10 |
410 |
M |
42 |
Pancreas |
Adenocarcinoma |
1 |
II |
T3N0M0 |
Malignant |
|
Q11 |
411 |
M |
63 |
Kidney |
Clear cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
Q12 |
412 |
M |
59 |
Kidney |
Clear cell carcinoma |
1 |
I |
T1N0M0 |
Malignant |
|
Q13 |
413 |
F |
47 |
Kidney |
Clear cell carcinoma (tumoral necrosis) |
– |
I |
T1N0M0 |
Malignant |
|
Q14 |
414 |
M |
54 |
Kidney |
Clear cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
Q15 |
415 |
M |
63 |
Kidney |
Clear cell carcinoma (sparse) |
– |
I |
T1N0M0 |
Malignant |
|
Q16 |
416 |
F |
32 |
Cervix uteri |
Squamous cell carcinoma (fibrous tissue and blood vessel) |
– |
IIa |
T2bN0M0 |
Malignant |
|
Q17 |
417 |
F |
32 |
Cervix uteri |
Squamous cell carcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
|
Q18 |
418 |
F |
43 |
Cervix uteri |
Squamous cell carcinoma (fibrous tissue and blood vessel) |
– |
I |
T1aN0M0 |
Malignant |
|
Q19 |
419 |
F |
47 |
Cervix uteri |
Squamous cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
Q20 |
420 |
F |
42 |
Cervix uteri |
Squamous cell carcinoma |
2 |
IIb |
T2bN0M0 |
Malignant |
|
Q21 |
421 |
M |
57 |
Esophagus |
Squamous cell carcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
Q22 |
422 |
M |
60 |
Esophagus |
Squamous cell carcinoma (sparse) |
– |
III |
T3N3M0 |
Malignant |
|
Q23 |
423 |
M |
56 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
Q24 |
424 |
M |
56 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
Q25 |
425 |
M |
54 |
Esophagus |
Squamous cell carcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
R1 |
426 |
M |
63 |
Liver |
Hepatocellular liver cancer |
2 |
III |
T3N0M0 |
Malignant |
|
R2 |
427 |
F |
63 |
Liver |
Hepatocellular liver cancer |
1 |
II |
T2N0M0 |
Malignant |
|
R3 |
428 |
M |
49 |
Liver |
Hepatocellular liver cancer |
3 |
III |
T3N0M0 |
Malignant |
|
R4 |
429 |
M |
63 |
Liver |
Hepatocellular liver cancer |
3 |
III |
T3N0M0 |
Malignant |
|
R5 |
430 |
M |
35 |
Liver |
Hepatocellular liver cancer |
3 |
II |
T2N0M0 |
Malignant |
|
R6 |
431 |
F |
72 |
Pancreas |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
R7 |
432 |
M |
59 |
Pancreas |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
R8 |
433 |
M |
57 |
Pancreas |
Adenocarcinoma (fibrous tissue and blood vessel) |
– |
II |
T3N0M0 |
Malignant |
|
R9 |
434 |
M |
49 |
Pancreas |
Adenocarcinoma |
2 |
III |
T3N1M0 |
Malignant |
|
R10 |
435 |
M |
67 |
Pancreas |
Adenocarcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
R11 |
436 |
M |
56 |
Kidney |
Clear cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
R12 |
437 |
M |
69 |
Kidney |
Clear cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
R13 |
438 |
M |
80 |
Kidney |
Clear cell carcinoma |
1 |
I |
T1N0M0 |
Malignant |
|
R14 |
439 |
F |
63 |
Kidney |
Clear cell carcinoma |
1 |
I |
T1N0M0 |
Malignant |
|
R15 |
440 |
M |
50 |
Kidney |
Clear cell carcinoma |
1 |
I |
T1N0M0 |
Malignant |
|
R16 |
441 |
F |
44 |
Cervix uteri |
Squamous cell carcinoma |
1 |
Ib |
T1bN0M0 |
Malignant |
|
R17 |
442 |
F |
56 |
Cervix uteri |
Squamous cell carcinoma |
1 |
IIa |
T2aN0M0 |
Malignant |
|
R18 |
443 |
F |
42 |
Cervix uteri |
Squamous cell carcinoma |
2 |
IIIb |
T1N1M0 |
Malignant |
|
R19 |
444 |
F |
44 |
Cervix uteri |
Squamous cell carcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
|
R20 |
445 |
F |
24 |
Cervix uteri |
Squamous cell carcinoma |
2 |
IIa |
T2aN0M0 |
Malignant |
|
R21 |
446 |
M |
72 |
Esophagus |
Adenocarcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
R22 |
447 |
M |
53 |
Esophagus |
Adenocarcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
|
R23 |
448 |
M |
71 |
Esophagus |
Adenocarcinoma |
2 |
III |
T4N0M0 |
Malignant |
|
R24 |
449 |
M |
56 |
Esophagus |
Adenocarcinoma |
2 |
IIa |
T3N0M0 |
Malignant |
|
R25 |
450 |
M |
62 |
Esophagus |
Adenocarcinoma |
3 |
III |
T3N1M0 |
Malignant |
|
S1 |
451 |
F |
43 |
Liver |
Hepatocellular liver cancer |
3 |
IVa |
T4N0M0 |
Malignant |
|
S2 |
452 |
M |
39 |
Liver |
Hepatocellular liver cancer |
3 |
III |
T3N0M0 |
Malignant |
|
S3 |
453 |
M |
56 |
Liver |
Hepatocellular liver cancer |
3 |
III |
T3N0M0 |
Malignant |
|
S4 |
454 |
M |
63 |
Liver |
Hepatocellular liver cancer |
3 |
III |
T3N0M0 |
Malignant |
|
S5 |
455 |
M |
65 |
Liver |
Hepatocellular liver cancer |
3 |
III |
T3N0M0 |
Malignant |
|
S6 |
456 |
M |
60 |
Pancreas |
Adenocarcinoma (chronic inflammation of fibrous tissue) |
– |
I |
T2N0M0 |
Malignant |
|
S7 |
457 |
F |
72 |
Pancreas |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
|
S8 |
458 |
F |
62 |
Pancreas |
Adenocarcinoma |
3 |
II |
T3N0M0 |
Malignant |
|
S9 |
459 |
M |
64 |
Pancreas |
Adenocarcinoma |
3 |
I |
T2N0M0 |
Malignant |
|
S10 |
460 |
M |
45 |
Pancreas |
Acinic cell carcinoma |
– |
I |
T2N0M0 |
Malignant |
|
S11 |
461 |
M |
40 |
Kidney |
Clear cell carcinoma (sparse) |
2 |
I |
T1N0M0 |
Malignant |
|
S12 |
462 |
M |
62 |
Kidney |
Clear cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
S13 |
463 |
M |
43 |
Kidney |
Clear cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
S14 |
464 |
M |
59 |
Kidney |
Clear cell carcinoma |
2 |
I |
T1N0M0 |
Malignant |
|
S15 |
465 |
M |
47 |
Kidney |
Clear cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
S16 |
466 |
F |
37 |
Cervix uteri |
Squamous cell carcinoma |
3 |
I |
T1N0M0 |
Malignant |
|
S17 |
467 |
F |
40 |
Cervix uteri |
Squamous cell carcinoma |
3 |
IIIb |
T1N1M0 |
Malignant |
|
S18 |
468 |
F |
54 |
Cervix uteri |
Squamous cell carcinoma |
3 |
I |
T1N0M0 |
Malignant |
|
S19 |
469 |
F |
55 |
Cervix uteri |
Squamous cell carcinoma |
3 |
Ia |
T1N0M0 |
Malignant |
|
S20 |
470 |
F |
60 |
Cervix uteri |
Squamous cell carcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
|
S21 |
471 |
M |
60 |
Esophagus |
Adenocarcinoma |
3 |
IIa |
T2N0M0 |
Malignant |
|
S22 |
472 |
M |
65 |
Esophagus |
Adenocarcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
S23 |
473 |
M |
63 |
Esophagus |
Adenocarcinoma |
3 |
IIa |
T3N0M0 |
Malignant |
|
S24 |
474 |
F |
67 |
Esophagus |
Adenocarcinoma |
3 |
III |
T4N0M0 |
Malignant |
|
S25 |
475 |
M |
57 |
Esophagus |
Adenocarcinoma |
3 |
III |
T4N0M0 |
Malignant |
|
T1 |
476 |
F |
50 |
Liver |
Normal liver tissue |
– |
– |
– |
Normal |
|
T2 |
477 |
M |
43 |
Liver |
Normal liver tissue |
– |
– |
– |
Normal |
|
T3 |
478 |
M |
45 |
Liver |
Normal liver tissue |
– |
– |
– |
Normal |
|
T4 |
479 |
M |
16 |
Liver |
Normal liver tissue |
– |
– |
– |
Normal |
|
T5 |
480 |
M |
40 |
Liver |
Normal liver tissue |
– |
– |
– |
Normal |
|
T6 |
481 |
M |
30 |
Pancreas |
Normal pancreatic tissue |
– |
– |
– |
Normal |
|
T7 |
482 |
F |
35 |
Pancreas |
Normal pancreatic tissue |
– |
– |
– |
Normal |
|
T8 |
483 |
F |
21 |
Pancreas |
Normal pancreatic tissue |
– |
– |
– |
Normal |
|
T9 |
484 |
M |
40 |
Pancreas |
Normal pancreatic tissue |
– |
– |
– |
Normal |
|
T10 |
485 |
M |
30 |
Pancreas |
Normal pancreatic tissue |
– |
– |
– |
Normal |
|
T11 |
486 |
F |
50 |
Kidney |
Normal kidney tissue |
– |
– |
– |
Normal |
|
T12 |
487 |
M |
50 |
Kidney |
Normal kidney tissue |
– |
– |
– |
Normal |
|
T13 |
488 |
F |
18 |
Kidney |
Normal kidney tissue |
– |
– |
– |
Normal |
|
T14 |
489 |
M |
16 |
Kidney |
Normal kidney tissue |
– |
– |
– |
Normal |
|
T15 |
490 |
M |
47 |
Kidney |
Normal kidney tissue |
– |
– |
– |
Normal |
|
T16 |
491 |
F |
51 |
Cervix uteri |
Normal cervical tissue (fibrous tissue and blood vessel) |
– |
– |
– |
NAT |
|
T17 |
492 |
F |
52 |
Cervix uteri |
Normal cervical tissue (fibrous tissue and blood vessel) |
– |
– |
– |
NAT |
|
T18 |
493 |
F |
50 |
Cervix uteri |
Normal cervical tissue (sparse) |
– |
– |
– |
NAT |
|
T19 |
494 |
F |
56 |
Cervix uteri |
Normal cervical tissue (sparse) |
– |
– |
– |
NAT |
|
T20 |
495 |
F |
35 |
Cervix uteri |
Normal cervical canals tissue |
– |
– |
– |
NAT |
|
T21 |
496 |
M |
35 |
Esophagus |
Normal esophageal tissue |
– |
– |
– |
Normal |
|
T22 |
497 |
M |
26 |
Esophagus |
Normal esophageal tissue (sparse) |
– |
– |
– |
Normal |
|
T23 |
498 |
F |
42 |
Esophagus |
Normal esophageal tissue (sparse) |
– |
– |
– |
Normal |
|
T24 |
499 |
M |
16 |
Esophagus |
Normal esophageal tissue |
– |
– |
– |
Normal |
|
T25 |
500 |
M |
43 |
Esophagus |
Normal esophageal tissue |
– |
– |
– |
Normal |
|
–
|
– |
F |
55 |
liver |
Hepatocellular liver cancer (tissue marker) |
3 |
|
T3N0M0 |
Malignant |
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum